维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：作者名="Heeckeren"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Drug insight: vascular disrupting agents and angiogenesis-novel approaches for drug delivery显示文摘	Cooney MM Van heeckeren W Bhakta S	2006	Nat Clin Pract Oncol2006，3，12：	1
	2	显示文摘	Day BJ van Heeckeren AM Min E	2004	Infect Immun2004，72，4：	1
	3	Vitamin D deficiency in Crohn′s disease and healthy controls: a prospective case-control study in the Netherlands显示文摘	de Bruyn JR van Heeckeren R Ponsioen CY	2014	J Crohns Colitis2014，8，10：	1
	4	Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma:in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 + cell enrichment device显示文摘	Vollweiler J Fu P	2006	Br J Haematol2006，132，1：	1
	5	Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists显示文摘	Van Heeckeren W J Bhakta S Ortiz J	2006	Journal of Clinical Oncology2006，24，10：	1
	6	Murine models of chronic Pseudomonas aeruginosa lung infection 显示文摘	van Heeckeren AM Schluchter MD	2002	Lab Anim2002，36，3：	1
	7	Management of nutritionai and infectious complications of postoperative chylothorax in children显示文摘	Allen EM Van Heeckeren DW Spector ML	1991	Pediatr Surg1991，26，：	1
	8	Randomised comparison of two B-cell purging protocols for patients with B-cell nonHodgkin lymphoma:in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device显示文摘	van Heeckeren W J Vollweiler J Fu P	2006	Br J Haematol2006，132，1：	1
	9	Hypertension,proteinuria,and antagonism of vascular endothelial growth factor signaling:clinical toxicity,therapeutic target,or novel biomarker显示文摘	van Heeckeren WJ Ortiz J Cooney MM		0，，21：	1
	10	Complications from vascular disrupting agents and angiogenesis inhibitors:aberrant control of hemostasis and thrombosis显示文摘	van Heeckeren WJ Sanborn SL Narayan A	2007	Curr Opin Hematol2007，14，5：	1
	11	Complications from vascular disrupting agents and angiogenesis inhibitors:aberrant control of hemostasis and thrombosis显示文摘	van Heeckeren WJ Sanborn SL Narayan A	2007	Curr Opin Hematol2007，14，5：	1
	12	Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis显示文摘	Willem J van Heeckeren Sharon L Sanborn Ajita Narayan Matthew M Cooney Keith R McCrae Alvin H Schmaier Scot C Remick	2007	Current Opinion in Hematology2007，，5：	1
	13	Murine models of chronic Pseudomonas aeruginosa lung infection 显示文摘	VAN HEECKEREN A M SCHLUCHTER M D	2002	Lab Anim2002，36，3：	1
	14	Hyperten- sion,proteinuria,and antagonism of vascular endothelial growth factor signaling: clinical toxicity,therapeutic tar- get, or novel biomarker? 显示文摘	van Heeckeren WJ Ortiz J Cooney MM	2007	J Clin Oncol2007，25，21：	1
	15	Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice 显示文摘	Velsor LW van Heeckeren A Day BJ	2001	Am J Physiol Lung Cell Mol Physio2001，281，：	1
	16	Primary pediatric cardic tumor: a 17 year experience 显示文摘	Sallee D Spector ML van Heeckeren DW	1999	Cardiol Yang1999，9，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费